ESR1 and breast cancer: The ER/E2 complex triggers several intracellular events linked to the overexpression of proteins associated to ER+ breast cancer cell proliferation (cyclin D1, p53, BRCA-1) and angiogenesis (VEGF-R2) (5–7).